Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Otherwise Healthy Obese Volunteers
Clinical trial NCT01756404 · COMPLETED
Trial details
- NCT number
- NCT01756404
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-14
- Primary completion
- 2007-12-05
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.